The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications

A Arcaro, AS Guerreiro - Current genomics, 2007 - ingentaconnect.com
The phosphoinositide 3-kinase (PI3K) pathway is frequently activated in human cancer and
represents an attractive target for therapies based on small molecule inhibitors. PI3K …

Specificity, selection and significance of gene amplifications in cancer

S Myllykangas, T Böhling, S Knuutila - Seminars in cancer biology, 2007 - Elsevier
DNA copy number amplifications activate oncogenes and are found in the majority of
advanced solid tumors. Cell-lineage specificity and oncogene affinity of DNA amplifications …

High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/akt pathway in thyroid tumors

Y Wang, P Hou, H Yu, W Wang, M Ji… - The Journal of …, 2007 - academic.oup.com
Context: Genetic alterations in the phosphatidylinositol-3-kinase (PI3K)/Akt pathway and
their role in thyroid tumor pathogenesis in Chinese people remain undefined. Objective: The …

PIK3CA mutation and amplification in human lung cancer

K Okudela, M Suzuki, S Kageyama… - Pathology …, 2007 - Wiley Online Library
To explore the significance of phosphatidylinositol‐3‐kinase, catalytic, alpha (PIK3CA) in the
carcinogenesis in human lung, mutations and copy number changes were investigated in …

Chromosomal aberrations and gene expression profiles in non-small cell lung cancer

E Dehan, A Ben-Dor, W Liao, D Lipson, H Frimer… - Lung cancer, 2007 - Elsevier
Alterations in genomic content and changes in gene expression levels are central
characteristics of tumors and pivotal to the tumorigenic process. We analyzed 23 non-small …

[HTML][HTML] Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NFκB-dependent pathway

D Xia, H Srinivas, Y Ahn, G Sethi, X Sheng… - Journal of Biological …, 2007 - ASBMB
Mitogen-activated protein kinase kinase-4 (MKK4/SEK1) cooperates with
phosphatidylinositol 3-kinase to maintain the survival of non-small cell lung cancer (NSCLC) …

PIK3CA gene amplification in Japanese non-small cell lung cancer

O Kawano, H Sasaki, K Okuda, H Yukiue, T Yokoyama… - Lung Cancer, 2007 - Elsevier
We have investigated 92 non-small cell lung cancer tissues and found 11 PIK3CA
amplification. PIK3CA amplification incidence was significantly higher in male, smoker and …

Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung

YW Choi, JS Choi, LT Zheng, YJ Lim, HK Yoon, YH Kim… - Lung cancer, 2007 - Elsevier
Genomic alterations have been identified in lung cancer tissues and reported in numerous
studies. To analyze genomic aberrations in lung cancer patients, we used array comparative …

[HTML][HTML] Aberrant DNA Methylation of OLIG1, a Novel Prognostic Factor in Non-Small Cell Lung Cancer

RM Brena, C Morrison, S Liyanarachchi… - PLoS …, 2007 - journals.plos.org
Background Lung cancer is the leading cause of cancer-related death worldwide. Currently,
tumor, node, metastasis (TNM) staging provides the most accurate prognostic parameter for …

The role of phosphoinositide 3-kinase pathway inhibitors in the treatment of lung cancer

JA Engelman - Clinical Cancer Research, 2007 - AACR
The phosphoinositide 3-kinase signaling network is widely implicated in the pathogenesis of
human cancer. This pathway is commandeered by cancer cells to promote unrestrained …